BIOMERICA INC Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested Options Forfeited, Weighted Average Grant Date Fair Value
BIOMERICA INC (BMRA) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested Options Forfeited, Weighted Average Grant Date Fair Value of $5.22 per share for the 12-month period ending 2022-05-31, per its 10-K filed 2022-08-29.
Discontinued › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Nonvested, Weighted Average Grant Date Fair Value
us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue · last filed 2022-08-29
- BIOMERICA INC share-based compensation arrangement by share-based payment award, options, nonvested options forfeited, weighted average grant date fair value for fiscal 2022 was $5.22, a 8.75% increase from fiscal 2021.
- BIOMERICA INC share-based compensation arrangement by share-based payment award, options, nonvested options forfeited, weighted average grant date fair value for fiscal 2021 was $4.80, a 35.21% increase from fiscal 2020.
- BIOMERICA INC share-based compensation arrangement by share-based payment award, options, nonvested options forfeited, weighted average grant date fair value for fiscal 2020 was $3.55, a 15.26% increase from fiscal 2019.
- BIOMERICA INC share-based compensation arrangement by share-based payment award, options, nonvested options forfeited, weighted average grant date fair value for fiscal 2019 was $3.08, a 97.44% increase from fiscal 2018.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested Options Forfeited, Weighted Average Grant Date Fair Value 12 month |
|---|---|
| 2022-05-31 | $5.22 10-K · filed 2022-08-29 |
| 2021-05-31 | $4.80 10-K/A · filed 2021-10-14 |
| 2020-05-31 | $3.55 10-K · filed 2020-08-31 |
| 2019-05-31 | $3.08 10-K · filed 2019-08-29 |
| 2018-05-31 | $1.56 10-K · filed 2018-08-29 |
| 2017-05-31 | $0.92 10-K · filed 2017-08-29 |
| 2016-05-31 | $0.77 10-K · filed 2016-08-29 |
| 2015-05-31 | $0.72 10-K · filed 2015-08-31 |
| 2014-05-31 | $0.43 10-K · filed 2014-08-29 |
| 2013-05-31 | $0.53 10-K · filed 2013-08-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |